About Novate
Novate is a Healthcare company based in Galway (Ireland) founded in 2006, and was acquired by BTG International in September 2018. Inferior vena cava filters are developed for pulmonary embolism treatment. Novate has raised $17.97 million across 2 funding rounds from investors including Enterprise Ireland, BTG International and Omnes Capital. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices.
Company details
Novate Medical was founded in 2006 in Galway, Ireland, and operates in the medical device sector. Focus is placed on inferior vena cava filters for pulmonary embolism prevention in high-risk patients. The lead product, Sentry, is a bio-convertible filter that provides protection during the high-risk period and bioconverts to an unobstructed lumen after at least 60 days. Enrollment in its FDA trial has been completed in the US and Europe.
- Headquarters Galway, Ireland
- Stage Acquired
- SectorsHealthcare
- Website novate.biz
- Acquired by BTG International (Sep 2018)
- Total Equity Funding$17.97M (USD)
in 2 rounds
- Latest Funding Round$12.42M (USD), Series B
May 2011
- InvestorsEnterprise Ireland
& 4 more
- Acquired byBTG International
(Sep 2018)
Funding Insights of Novate
Novate has successfully raised a total of $17.97M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.42 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.97M
- Total Rounds 2
- Last Round Series B β $12.42M
- First Round $5.55M
(Sep 2007)
- Investors Count 4
All 2 funding rounds of Novate with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2011 | $12.42M | Series B | β | Omnes Capital, Seroba Life Sciences | |
| Sep 2007 | $5.55M | Series A | β | Act Venture Capital |
5 investors in total: 5 institutional.
Investors in Novate
Novate has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Enterprise Ireland, BTG International and Omnes Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity firm focused on energy transition and sustainable investments across Europe. | omnescapital.com | |||
Early-stage venture capital funding is provided to innovative companies. | actventure.capital | Dublin, Ireland | ||
Seroba Lifesciences is focused on life sciences venture capital investments. | seroba-lifesciences.com | Dublin, Ireland | ||
Support is provided to Irish manufacturing and service sector businesses. | 1998 | enterprise-ireland.com | Dublin, Ireland | |
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments. | 1948 | btgplc.com | London, United Kingdom |
Investor details for Novate
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Novate
1150 people are tracked at Novate (315 in leadership, 9 in board & advisors, 826 in team).
| Name | Role | Group |
|---|---|---|
Augusto Chaves | IT PMO & Finance Head | Leadership |
Genevieve Morrison | IT Director, Acquisition & Integrations | Leadership |
David Sapienza | VP Global Operation Distribution And Logistics | Leadership |
Nikunj Murgai | Director, IT | Leadership |
Jodi Eddy | Senior Vice President, Enterprise Services and Digital Officer | Leadership |
Siri Thompson | Vice President, Program Management LAAC | Leadership |
Lance Bates | SVP & President, Interventional Cardiology Therapies | Leadership |
Alex Pflugfelder | Director - Upstream EP Marketing, EP Commercial Development Team | Leadership |
Sofía Leiva | HR Specialist - People Services Partner Latam | Leadership |
Zoe Heuver | Supply Chain Partner | Leadership |
Charles K. | Director, Quality | Leadership |
Ahmed Abdelaal | Chief Medical Officer | Leadership |
Lillian Kerrigan | Director Global Quality Design Controls And Acquisitions | Leadership |
Viktoriya Skuz | People Partner I | Leadership |
Kelly Schwenn | Director Of Program Management, Arden Hills And North America Manufacturing | Leadership |
Charudatta Aradhye | Associate Director, R&D | Leadership |
Sandra Nagale | Director, Digital Health Products, Platforms & AI | Leadership |
Gary Leblanc | Director Of Quality | Leadership |
Janet Bukovcan | Director, Regulatory Affairs | Leadership |
Philip Sinclair | Vice President, Global Medical Affairs And Clinical Development, Interventional Oncology | Leadership |
1130 more people are available in the full profile.
Complete people profiles for Novate
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Novate
4 dated milestones of Novate across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Novate is founded.
- Funding First funding round of $5.5M.
- Funding Latest funding round, Series B, of $12.4M.
- Exit Acquired by BTG International.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Novate
Complete news archive for Novate
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novate
Novate was founded in 2006 and raised its 1st funding round 1 year after it was founded.
Novate is headquartered in Galway, Ireland.
Novate is a funded company, having raised a total of $17.97M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5.55M, raised on Sep 2007.
Novate Medical was founded in 2006 in Galway, Ireland, and operates in the medical device sector. Focus is placed on inferior vena cava filters for pulmonary embolism prevention in high-risk patients. The lead product, Sentry, is a bio-convertible filter that provides protection during the high-risk period and bioconverts to an unobstructed lumen after at least 60 days. Enrollment in its FDA trial has been completed in the US and Europe.
Novate has 5 investors. Key investors include Enterprise Ireland, BTG International, Omnes Capital, Seroba Lifesciences, and Act Venture Capital.
Yes. Novate was acquired by BTG International in September 2018.

